1.
OncoImmune machine-learning model predicts immune response and prognosis in leiomyosarcoma. Biomol Biomed [Internet]. 2025 Jun. 4 [cited 2025 Jun. 13];. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/12342